KR860002508A - 푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물 - Google Patents

푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물 Download PDF

Info

Publication number
KR860002508A
KR860002508A KR1019850007089A KR850007089A KR860002508A KR 860002508 A KR860002508 A KR 860002508A KR 1019850007089 A KR1019850007089 A KR 1019850007089A KR 850007089 A KR850007089 A KR 850007089A KR 860002508 A KR860002508 A KR 860002508A
Authority
KR
South Korea
Prior art keywords
compound
group
hydrogen
iii
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019850007089A
Other languages
English (en)
Korean (ko)
Inventor
위크(외 2) 알렉산더
Original Assignee
에뚜레-레메뜨르
신떼라보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에뚜레-레메뜨르, 신떼라보 filed Critical 에뚜레-레메뜨르
Publication of KR860002508A publication Critical patent/KR860002508A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
KR1019850007089A 1984-09-27 1985-09-26 푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물 Ceased KR860002508A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR84/14842 1984-09-27
FR8414842A FR2570701B1 (fr) 1984-09-27 1984-09-27 Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
KR860002508A true KR860002508A (ko) 1986-04-26

Family

ID=9308136

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007089A Ceased KR860002508A (ko) 1984-09-27 1985-09-26 푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물

Country Status (19)

Country Link
US (1) US4661498A (enExample)
EP (1) EP0178201B1 (enExample)
JP (1) JPS61106577A (enExample)
KR (1) KR860002508A (enExample)
AT (1) ATE40554T1 (enExample)
AU (1) AU573390B2 (enExample)
CA (1) CA1291994C (enExample)
DE (1) DE3568045D1 (enExample)
DK (1) DK158953C (enExample)
ES (1) ES8605522A1 (enExample)
FI (1) FI82054C (enExample)
FR (1) FR2570701B1 (enExample)
GR (1) GR852356B (enExample)
HU (1) HU192365B (enExample)
IL (1) IL76535A0 (enExample)
NO (1) NO162821C (enExample)
NZ (1) NZ213620A (enExample)
PT (1) PT81206B (enExample)
ZA (1) ZA857457B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566775B1 (fr) * 1984-06-27 1986-10-31 Synthelabo Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
FR2635977B1 (fr) * 1988-09-07 1992-05-15 Synthelabo Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA70334C2 (en) 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
HK1045686B (zh) * 1998-12-21 2005-04-01 詹森药业有限公司 作为α2-拮抗剂的苯并异恶唑和苯基酮
DE60028538T2 (de) * 1999-01-19 2007-06-21 Neurosearch A/S Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (enExample) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
DD210278A5 (de) * 1982-03-05 1984-06-06 Boehringer Ingelheim Kg Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine

Also Published As

Publication number Publication date
FR2570701A1 (fr) 1986-03-28
AU573390B2 (en) 1988-06-09
FR2570701B1 (fr) 1987-05-22
FI82054B (fi) 1990-09-28
EP0178201B1 (fr) 1989-02-01
AU4795285A (en) 1986-04-10
US4661498A (en) 1987-04-28
FI853719A0 (fi) 1985-09-26
DK435285A (da) 1986-03-28
ATE40554T1 (de) 1989-02-15
FI853719L (fi) 1986-03-28
JPS61106577A (ja) 1986-05-24
HU192365B (en) 1987-05-28
NO162821B (no) 1989-11-13
ZA857457B (en) 1986-05-28
PT81206B (pt) 1988-01-22
ES547315A0 (es) 1986-03-16
HUT38945A (en) 1986-07-28
IL76535A0 (en) 1986-02-28
DE3568045D1 (en) 1989-03-09
GR852356B (enExample) 1986-01-28
EP0178201A1 (fr) 1986-04-16
PT81206A (fr) 1985-10-01
CA1291994C (en) 1991-11-12
DK158953C (da) 1991-01-14
FI82054C (fi) 1991-01-10
NZ213620A (en) 1988-01-08
NO162821C (no) 1990-02-21
NO853782L (no) 1986-04-01
ES8605522A1 (es) 1986-03-16
DK158953B (da) 1990-08-06
DK435285D0 (da) 1985-09-26

Similar Documents

Publication Publication Date Title
GR3005315T3 (enExample)
KR910011887A (ko) 신규 a-노르-스테로이드-3-카르복실산 유도체
ATE295173T1 (de) Pteridinderivat enthaltende pharmazeutische zusammensetzung
KR830004277A (ko) 모르폴린 유도체
AU6791781A (en) Piperazino phenylindane
EP0614913A3 (en) Dynorphin derivatives.
KR860002508A (ko) 푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물
KR890009910A (ko) 사이클릭 아미노산 유도체, 이의 제조 방법, 이를 함유하는 제제 및 이의 용도
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
KR920004392A (ko) 플루오로에틸캄프토테신 유도체
GB1412932A (en) Pharmaceutically active leurosine derivatives and preparation thereof
KR880005128A (ko) 이미다조[4,5-b]피리딘-2-온 유도체, 그의 제법 및 치료에의 응용
KR910000648A (ko) 페녹시피리딘아민 및 이의 유도체, 제조방법 및 약제로서의 용도
KR910011777A (ko) 피롤알데히드 유도체, 그의 제조방법 및 이 화합물을 함유하는 제약조성물
KR830005151A (ko) 헤테로 시클릭 화합물의 제조 방법 및 이것의 조성물
HUT45059A (en) Process for producing abeoergoline derivatives
KR840001154A (ko) 1,2-디티올-3-일리덴 암모늄 유도체의 제조방법
HK57893A (en) Asymmetric synthesis of furo[3,4-c]pyridine derivatives
KR890009896A (ko) 디옥사조신 유도체, 그의 제법 및 그를 함유하는 조성물
ATE55988T1 (de) Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung.
GB1418831A (en) Reserpine derivatives
KR910011863A (ko) 시네르지스틴 유도체, 그의 제조 방법 및 그의 사용
KR850007599A (ko) 3-아지노메틸 리파마이신의 제조방법
KR900012934A (ko) 피리도 피리미딘 유도체, 이들을 함유하는 약학적 조성물 및 이들을 제조하는 제조방법
EP0318166A3 (en) Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850926

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19900702

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19850926

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19920630

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19920909

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19920630

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I